Specifically, NAD+ administration increased intracellular ATP levels via the activation of SIRT2, which regulates Akt phosphorylation in BV2 microglial cells [103], while NR treatment alleviated cisplatin-induced peripheral neuropathy in a SIRT2-dependent manner [104]. This evidence concerns the gene SIRT2 and peripheral neuropathy.